Atlas Trials

Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial

Clinical trial NCT01149369 · COMPLETED

Trial details

NCT number
NCT01149369
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroparesis
Start date
2013-04-01
Primary completion
2015-08-01
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.